Verrica Pharmaceuticals 2024 Company Overview - YCANTH Molluscum Contagiosum

Loading viewer...

investor_presentation

Format: PDF investor_presentation

Verrica Pharmaceuticals presents company overview highlighting the FDA approval of YCANTH™, the first FDA-approved treatment for molluscum contagiosum. The presentation covers Verrica's business strategy, clinical programs, and commercial launch plans for its lead product candidate.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Verrica Pharmaceuticals

View all →

Verrica Pharmaceuticals Company Overview 2024

investor_presentation

59 Pages

Similar investor_presentations from other companies

Browse all →

CL Educate Limited Q1 FY2021 Investor Presentation

investor_presentation

30 Pages

CL Educate Limited

JSW Steel Limited 2021 Corporate Presentation

investor_presentation